Related references
Note: Only part of the references are listed.Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3β
Wen Min Lau et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Kathleen A. Cronin et al.
CANCER (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Genetic and transcriptional evolution alters cancer cell line drug response
Uri Ben-David et al.
NATURE (2018)
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes
Bastiaan Evers et al.
NATURE BIOTECHNOLOGY (2016)
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
Andrew J. Aguirre et al.
CANCER DISCOVERY (2016)
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
Alex Pearson et al.
CANCER DISCOVERY (2016)
Epithelial-mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells
Paulina Grygielewicz et al.
GASTRIC CANCER (2016)
Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
Wei Li et al.
GENOME BIOLOGY (2015)
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
X. Su et al.
BRITISH JOURNAL OF CANCER (2014)
GSK-3-at the crossroads of cell death and survival
Ulrich Maurer et al.
JOURNAL OF CELL SCIENCE (2014)
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
Kai Wang et al.
NATURE GENETICS (2014)
Selective regulation of p38β protein and signaling by integrin-linked kinase mediates bladder cancer cell migration
L. Yu et al.
ONCOGENE (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer
Lincoln D. Nadauld et al.
GENOME BIOLOGY (2014)
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li et al.
GENOME BIOLOGY (2014)
Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase
Isabel Serrano et al.
NATURE COMMUNICATIONS (2013)
Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
Levi A. Garraway et al.
CANCER DISCOVERY (2012)
Identification and Characterization of a Novel Integrin-Linked Kinase Inhibitor
Su-Lin Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer
S. M. Pontier et al.
ONCOGENE (2010)
Tumor expression of Integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor Snail: an immunohistochemical study in ductal pancreatic adenocarcinoma
David F. Schaeffer et al.
VIRCHOWS ARCHIV (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Integrin-linked kinase - essential roles in physiology and cancer biology
Paul C. McDonald et al.
JOURNAL OF CELL SCIENCE (2008)
The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways
Eleonore Beurel et al.
PROGRESS IN NEUROBIOLOGY (2006)
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
U Maurer et al.
MOLECULAR CELL (2006)
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells
GE Konecny et al.
CANCER RESEARCH (2006)
Integrin-linked kinase: A cancer therapeutic target unique among its ILK
G Hannigan et al.
NATURE REVIEWS CANCER (2005)
Glycogen synthase kinase-3β phosphorylates bax and promotes its mitochondrial localization during neuronal apoptosis
DA Linseman et al.
JOURNAL OF NEUROSCIENCE (2004)
Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes
CY Wu et al.
JOURNAL OF CELL BIOLOGY (2001)
Share Paper
